Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Alliance Seeks to Forestall EU Legislation Threat to MRI

By HospiMedica International staff writers
Posted on 26 Jul 2011
A coalition of European Parliamentarians, patient groups, leading European scientists, and the medical community are seeking to avert the serious threat posed by European Union (EU) health and safety legislation to the clinical and research use of magnetic resonance imaging (MRI).

The Alliance for MRI (Vienna, Austria) was officially launched in March 2007 in response to the implementation deadline of the EU Physical Agents 2004/40/EC (EMF) in April 2008. More...
The Alliance was founded by the European Society of Radiology (ESR; Vienna, Austria), the European Federation of Neurological Associations (Billingshurst, West Sussex, UK), and Dr. Swoboda MEP, vice-chairman of the Socialist Group in the European Parliament.

In October 2007, the European Commission recognized the problem of MRI in Directive 2004/40/EC and proposed the first-ever postponement of an implementation deadline from April 2008 to April 2012 to allow time for scientific studies to study the impact of the Directive on the use of MRI. These studies confirmed that the exposure limits in the directive were detrimental to patient care. They would restrict and limit the use of MRI in interventional applications and in imaging vulnerable patients and children where closer patient contact is required. Furthermore, new research and developments in MRI would be severely restricted, as will routine cleaning and maintenance of MRI equipment.

Following additional consultations, the Commission decided to revise the Directive in order to find a lasting solution for MR culminating in the current proposal. The Alliance for MRI was instrumental in bringing about this revision.

MRI has been used for over 25 years, imaging up to 500 million patients without evidence of harm to workers due to EMF exposure. It is also well known that MRI is free from most health risks associated with ionizing radiation such as X-rays, which would form the alternative to MRI in many situations.

MRI is central to the diagnosis and treatment of major life-threatening diseases such as cancer, cardiovascular diseases, musculoskeletal, and neurologic disorders. Emerging molecular MR imaging techniques are poised to make major contributions in the area of oncology. Currently MRI is the most accurate tool for detecting breast cancer in young patients with genetic predisposition. Cardiac MRI has made huge strides in recent years, for example allowing for the assessment of the functioning of heart muscle in heart-attack patients. Functional MRI, mapping out areas of the brain that are responsible for specific sensory and motor tasks, is making significant contributions to neuroscience as well as improving the outcome of brain surgery for patients.

Moreover, a number of individual scientists and patient group representatives have signed up to the Alliance. “This proposal is good news for patients around Europe, and we look forward to its quick adoption, which will clarify the law on MRI,” said Hannes Swoboda, a leading member of the European Parliament and founding member of the Alliance for MRI.

“Europe is currently at the forefront of this technology and with this revision the Commission demonstrated that it supports this vital technology,” said Prof. Gabriel Krestin, vice-president of the European Society of Radiology.

Related Links:

Alliance for MRI
European Society of Radiology
European Federation of Neurological Associations



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Critical Care Conversion Kit
Adapter+
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.